Evidence for endothelin involvement in the pulmonary vasoconstrictor response to systemic hypoxia in the isolated rat lung

Journal of Pharmacology and Experimental Therapeutics

Volumn 283, Issue 2, 1997, Pages 419-425

  Smith, R M ^a   Brown, T J ^b   Roach, A G ^b   Williams, K I ^a   Woodward, B ^a  

^a University of Bath   (United Kingdom)

^b Discovery Biology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BOSENTAN; COLCHICINE; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOHEXIMIDE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; PHALLOIDIN; PHOSPHORAMIDON;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HYPOXIA; ISOLATED LUNG; LUNG BLOOD VESSEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

ANIMALS; ANOXIA; COLCHICINE; CYCLOHEXIMIDE; ENDOTHELINS; LUNG; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PERFUSION; PIPERIDINES; RATS; RATS, WISTAR; VASOCONSTRICTION;

EID: 0030786097     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. BARNES, P. J.: Endothelins and pulmonary disease. J. Appl. Physiol. 77: 1051-1059, 1994.
2. A receptor antagonist, attenuates endothelin-1-induced vasoconstriction in rat pulmonary circulation. J. Cardiovasc. Pharmacol. 22: 39-43, 1993.
3. BORISY, G. G. AND TAYLOR, E. W.: The mechanism of action of colchicine: Colchicine binding to sea urchin eggs and the mitotic apparatus. J. Cell. Biol. 34: 535-549, 1967.
4. CHEN, S. J., MENG, Q., ELTON, T., YANO, M., OPARIL, S. AND CHEN, Y. F.: Endothelin-A receptor antagonist (BQ-123) prevents acute hypoxia-induced pulmonary hypertension in rats. FASEB J. 7: A649, 1993.
5. CHEN, S. J., MENG, Q. C. AND OPARIL, S.: The endothelin receptor antagonist bosentan prevents short-term hypoxia-induced pulmonary hypertension in rats. Circulation 90: 1151, 1994.
6. CLOZEL, M., BREU, V., GRAY, G. A., KALINA, B., LOFFLER, B., BURRI, K., CASSAL, J., HIRTH, G., MULLER, M., NEIDHART, W. AND RAMUZ, H.: Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J. Pharmacol. Exp. Ther. 270: 228-235, 1994.
7. DEMIRYUREK, A. T., MACLEAN, M. R., WADSWORTH, R. M. AND KANE, K. A.: Effects of hypoxia on endothelin-1 release from human, sheep and rabbit pulmonary artery rings. Endothelium 1: 251-258, 1994.
8. DICARLO, V. S., CHEN, S. J., CHEN, Y. F., YANO, M. AND OPARIL, S.: Chronic blockade of endothelin-A receptors with BQ-123 prevents hypoxia-induced pulmonary hypertension and pulmonary vascular remodeling in rats. Circulation 90: 16, 1994.
9. EDDAHIBI, S., RAFFESTIN, B., CLOZEL, M., LEVAME, M. AND ADNOT, S.: Protection from pulmonary hypertension with an orally active endothelin receptor antagonist in hypoxic rats. Am. J. Physiol. 268: H828-H835, 1995.
10. FERRI, C., BELLINI, C., DEANGELIS, C., DESIATI, L., PERRONE, A., PROPERZI, G. AND SANTUCCI, A.: Circulating endothelin-1 concentrations in patients with chronic hypoxia. J. Clin. Pathol. 48: 519-524, 1995.
11. A receptors. Br. J. Pharmacol. 109: 880-886, 1993.
12. FISHMAN, A. P.: Hypoxia on the pulmonary circulation: How and where it acts. Circulation Res. 38: 221-231, 1976.
13. FUKURODA, T., NOGUCHI, K., TSUCHIDA, S., NISHIKIBE, M., IKEMOTO, F., OKADA, K. AND YANO, M.: Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun. 172: 390-395, 1990.
14. GOERRE, S., WENK, M., BARTSCH, P., LUSCHER, T. F., NIROOM, F., HOENHAUS, E., OELZ, O. AND REINHART, W.: Endothelin-1 in pulmonary hypertension associated with high altitude exposure. Circulation 91: 359-364, 1995.
15. HIEDA, H. S. AND GOMEZ-SANCHEZ, C. E.: Hypoxia increases endothelin release in bovine endothelial cells in culture, but epinephrine, norepinephrine, serotonin, histamine and angiotensin II do not. Life Sci. 47: 247-51, 1990.
16. A receptor. Life. Sci. 50: 247-255, 1992.
17. ISHIKAWA, K., IHARA, M., NOGUCHI, K., MASE, T., MINO, N., SAEKI, T., FUKURODA, T., FUKAMI, T., OZAKI, S., NAGASE, T., NISHIKIBE, M. AND YANO, M.: Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788. Proc. Natl. Acad. Sci. USA 91: 4892-4896, 1994.
18. JENSEN, K. S., MICCO, A. J., CZARTOLOMNA, J., LATHAM, L. AND VOELKEL, N. F.: Rapid onset of hypoxic vasoconstriction in isolated lungs. J. Appl. Physiol. 72: 2018-2023, 1992.
19. JIN, N., PACKER, C. S. AND RHOADES, R. A.: Pulmonary arterial hypoxic contraction: Signal transduction. Am. J. Physiol. 263: L73-L78, 1992.
20. KITAZUMI, K., MIO, M. AND TASAKA, K.: Involvement of the microtubular system in the endothelin-1 secretion from porcine aortic endothelial cells. Biochem. Pharmacol. 42: 1079-1085, 1991.
21. KOUREMBANAS, S., MARSDEN, P. A., MCQUILLAN, L. P. AND FALLER, D. V.: Hypoxia induces endothelin gene expression and secretion in cultured human endothelium. J. Clin. Invest. 88: 1054-1057, 1991.
22. KUROSE, I., MIURA, S., FUKUMURA, D. AND TSUCHIYA, M.: Mechanisms of endothelin-induced macromolecular leakage in microvascular beds of rat mesentery. Eur. J. Pharmacol. 250: 85-94, 1993.
23. LAL, H., WOODWARD, B. AND WILLIAMS, K. I.: Differential effects of agents on bronchial and vascular tone and lung weight in the rat isolated perfused lung. Pul. Pharmacol. 7: 271-278, 1994.
24. LAL, H., WOODWARD, B. AND WILLIAMS, K. I.: Actions of endothelins and sarafotoxin 6c in the rat isolated perfused lung. Br. J. Pharmacol. 115: 653-659, 1995.
25. LAL, H., WOODWARD, B. AND WILLIAMS, K. I.: Investigation of the contribution of nitric oxide and prostaglandins to the actions of endothelins and sarafotoxin 6c in rat isolated perfused lungs. Br. J. Pharmacol. 118: 1931-1938, 1996.
26. LI, H., ELTON, E. S., CHEN, Y. F. AND OPARIL, S.: Increased endothelin receptor gene expression in hypoxic rat lung. Am. J. Physiol. 266: 553-560, 1994.
27. MATSUMURA, Y., HISAKI, K., TAKAOKA, M. AND MORIMOTO, S.: Phosphoramidon, a metalloproteinase inhibitor, suppresses the hypertensive effect of big endothelin-1. Eur. J. Pharmacol. 185: 103-106, 1990.
28. MCCULLOCHH, K. M., DOCHERTY, C. C., MORECROFT, I. AND MACLEAN, M. R.: Endothelin mediated receptor contraction in human pulmonary resistance arteries. Br. J. Pharmacol. 119: 1125-1130, 1996.
29. MCMAHON, E. G., PALOMO, M. A., MOORE, W. M., MCDONALD, J. F. AND STERN, M. K.: Phosphoramidon blocks the pressor activity of big porcine endothelin-1-(1-39) in vivo and conversion of big endothelin-1-(1-39) to endothelin-1-(1-21) in vitro. Proc. Natl. Acad. Sci. USA 88: 703-707, 1991.
30. OBRIG, T. G., CULP, W. J., MCKEEHAN, W. L. AND HARDESTY, B.: The mechanism by which cycloheximide and related glutarimide antibiotics inhibit peptide synthesis on reticulocyte ribosomes. J. Biol. Chem. 246: 174-181, 1971.
31. OPARIL, S., CHEN, S. J., MENG, Q. C., ELTON, T. S., YANO, M. AND CHEN, Y. F.: Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in rat. Am. J. Physiol. 268: L95-L100, 1995.
32. RODMAN, D. M., YAMAGUCHI, T., O'BREIN, R. F. AND MCMURTRY, I. F.: Hypoxic contraction of rat isolated pulmonary artery. J. Pharmacol. Exp. Ther. 248: 952-959, 1989.
33. ROLINSKI, B., SADRI, I., BOGNER, J. AND GOEBEL, F. D.: Determination of endothelin-1 immunoreactivity in plasma, cerebrospinal fluid and urine. Res. Exp. Med. 194: 9-24, 1994.
34. SAWAMURA, T., KASUYA, Y., MATSUSHITA, Y., SUZUKI, N., KISHI, N., SUGITA, Y., YANAGISAWA, M., GOTO, K., MASAKI, T. AND KIMURA, S.: Phosphoramidon inihibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells. Biochem. Biophys. Res. Commun. 174: 779-784, 1991.
35. SHIRAKAMI, G., NAKAO, K., SAITO, Y., MAGARIBUCHI, T., JOUGASAKI, M., MUKOYAMA, M., ARAI, H., HOSODA, K., SUGA, S., OGAWA, Y., YAMADA, T., MORI, K. AND IMURA, H.: Acute pulmonary alveolar hypoxia increases lung and plasma endothelin-1 levels in conscious rats. Life Sci. 48: 969-976 (1991).
36. SMITH, R. M., ROACH, A. G., WILLIAMS, K. I. AND WOODWARD, B.: Effects of cytoskeletal modifying agents on systemic hypoxic vasoconstriction and oedema formation in the rat isolated perfused lung. Br. J. Pharmacol. 116: 302P, 1995a
37. SMITH, R. M., WILLIAMS, K. I. AND WOODWARD, B.: Evidence for endothelin involvement in hypoxic vasoconstriction in the rat isolated perfused lung. Br J. Pharmacol. 116: 35P, 1995b.
38. TAKEOKA, M., ISHIZAKI, T., SAKAI, A., CHANG, S. W., SHIGIMORI, K., HIGASHI, T. AND UEDA, G.: Effect of BQ123 on vasoconstriction as a result of either hypoxia or endothelin-1 in perfused rat lungs. Acta Physiol. Scand. 155: 53-60, 1995.
39. TASAKA, K. AND KITAZUMI, K.: The control of endothelin-1 secretion. Gen. Pharmacol. 25: 1059-1069, 1994.
40. VEMULAPALLI, S., CHIU, P. J. S., GRISCTI, K., BROWN, A., KUROWSKI, S. AND SYBERTZ, E. J.: Phosphoramidon does not inhibit endogenous endothelin-1 release stimulated by hemorrhage, cytokines and hypoxia in rats. Eur. J. Pharmacol. 257: 95-102, 1994.
41. VEMULAPALLI, S., RIVELLI, M., CHIU, P. J. S., DEL PRADO, M. AND HEY, J. A.: Phosphoramidon abolishes the increase in endothelin-1 release induced by ischemia-reperfusion in isolated perfused guinea-pig lungs. J. Pharmacol. Exp. Ther. 262: 1062-1069, 1992.
42. WADSWORTH, R. M.: Vasoconstrictor and vasodilator effects of hypoxia. Trends Pharmacol. Sci. 15: 47-53, 1994.
43. WARD, J. P. T. AND ROBERTSON, T. P.: The role of the endothelium in hypoxic pulmonary vasoconstriction. Exp. Physiol. 80: 793-781, 1995.
44. WEIR, E. K. AND ARCHER, S. L.: The mechanism of acute pulmonary vasoconstriction: The tale of two channels. FASEB J. 9: 183-189, 1995.
45. XIA, N. Y. AND NYE, P. C. G.: Effects of an endothelin receptor blocker on constriction of small isolated pulmonary-arteries of the rat. J. Physiol. 487P: 113-114, 1995.